Online Continuing Education for Healthcare Providers

Healthcare-education-elearning

The client, a global leader in rapid diagnostics, joined the White House Antibiotic Stewardship Forum and offered its commitments to support and advance the President’s National Action Plan to Combat Antibiotic-Resistant Bacteria.

Forward Eye brings a unique combination of cross-pollinized expertise in the areas of digital learning, digital marketing and digital enterprise solutions. Forward Eye consulted the client in designing and implementing its online education and outreach campaign strategy. We helped in successful realization of the stewardship program from the conceptualization stage.

  • Consulted on the strategy for antibiotic stewardship education campaign for healthcare providers
  • Design and communications blueprint for online campaign and educational materials
  • Partnered with vendor agencies to design and develop online continuing education materials including a series of Continuing Medical Education (CME) accredited, patient cases studies and elearning courses

Forward Eye’s integrated digital marketing solution mapped to digital learning needs helped the client achieve the following:

  • Advance public awareness and knowledge
  • Strengthen infectious disease prevention capability and treatment decisions
  • Educate public around institutional and governmental antimicrobial policy
  • Build local microbiology surveillance and diagnostics capacity

To learn about how digital marketing expertise helped accelerate digital learning needs, write to us at info@forwardeye.com.

Features

  • Managed Marketing Services
  • Online CME Courses
  • Online Marketing Communications
Share

Related Work

Prescribing Information Interactive for Pharmaceutical Sales Teams

Prescribing Information Interactive for Pharmaceutical Sales Teams

The company is a Fortune 500 rated and world leader in manufacturing and marketing therapeutic drugs. The company markets an anti-cancer drug acting as a selective proteasome inhibitor. The U.S. Food and Drug Administration (FDA) approved the drug on 20 July 2012 for use in patients with multiple myeloma. Three years after FDA approved the expanded use of the

Regulatory And Compliance Training- Active Pharmaceutical Ingredient Manufacturer

Regulatory And Compliance Training- Active Pharmaceutical Ingredient Manufacturer

The client is a multinational pharmaceutical company headquartered in India and operations in over 20 countries across the globe. The company has over 190 medications, 60 active pharmaceutical ingredients (APIs) for drug manufacture, diagnostic kits, critical care, and biotechnology products. In 2015, the client experienced a significant number of non-compliance escalations in its API manufacturing divisions and specifically